The CoV2 test principle is straightforward How do we make it high throughput?
3
CoV2 test steps
4
CoV2 assay targets
5
CoV2 assay details
6
Test development timeline
7
Virus inactivation
8
RNA extraction
9
Sample processing pipeline - throughput
10
Equipment stoichiometry - one 'line' PRL NYC has three lines operating
11
Sample tracking and analysis - DaViD
12
Future of sample tracking
13
DaViD-analysis interface
14
Test statistics
15
Current optimization work
16
Changing sample collection paradigm
17
Pooled testing
18
At-home saliva collection
19
What's next for PRL testing?
20
CoV2 whole genome sequencing
21
Sequencing pipeline is integrated into the testing line
22
Sequencing pipeline overview
23
Sequencing development timeline
24
GISAID submissions by state
25
Variant growth over time
26
NYC variant sequences from PRL
27
NYC variant distributions from PRL
28
NYC variant distributions - B.1.1.7
29
NYC variant distributions - B.1.526 +E484K
30
PRL testing vs sequencing distribution
31
Executive team
32
Scientific Advisory Board
33
The team that does it all
Description:
Explore a keynote presentation on high-throughput diagnostics and sequencing at the Pandemic Response Lab in New York City. Delve into the efforts to control the spread of SARS-CoV-2 through widespread testing and monitoring of emerging variants. Learn about the CoV2 test principle, virus inactivation, RNA extraction, and sample processing pipeline. Discover the equipment stoichiometry, sample tracking, and analysis using the DaViD system. Examine current optimization work, including pooled testing and at-home saliva collection. Investigate the integrated CoV2 whole genome sequencing pipeline, development timeline, and variant growth over time. Analyze NYC variant distributions, focusing on B.1.1.7 and B.1.526 +E484K strains. Gain insights into the executive team, Scientific Advisory Board, and the dedicated professionals behind these crucial pandemic response efforts.
High-throughput Diagnostics and Sequencing at the Pandemic Response Lab NYC